Exelixis

YTD

ALL

Trade Exelixis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,147

Employees1,147

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,147

Employees1,147

EXEL Key Statistics

Market cap

10.13B

Market cap10.13B

Price-Earnings ratio

20.56

Price-Earnings ratio20.56

Dividend yield

—

Dividend yield—

Average volume

2.72M

Average volume2.72M

High today

$36.48

High today$36.48

Low today

$35.73

Low today$35.73

Open price

$36.03

Open price$36.03

Volume

2.23M

Volume2.23M

52 Week high

$40.02

52 Week high$40.02

52 Week low

$20.14

52 Week low$20.14

EXEL News

Simply Wall St 3d

Market Participants Recognise Exelixis, Inc.'s Earnings

Exelixis, Inc.'s ( ) price-to-earnings (or "P/E") ratio of 19.6x might make it look like a sell right now compared to the market in the United States, where aro...

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

47.6%

Sell